EP0236475A1 - Method of preparing a yeast-cell lytic enzyme system - Google Patents
Method of preparing a yeast-cell lytic enzyme systemInfo
- Publication number
- EP0236475A1 EP0236475A1 EP86906046A EP86906046A EP0236475A1 EP 0236475 A1 EP0236475 A1 EP 0236475A1 EP 86906046 A EP86906046 A EP 86906046A EP 86906046 A EP86906046 A EP 86906046A EP 0236475 A1 EP0236475 A1 EP 0236475A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- activity
- dilution rate
- glucanase
- yeast
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 title claims abstract description 30
- 210000005253 yeast cell Anatomy 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims description 53
- 238000010790 dilution Methods 0.000 claims abstract description 116
- 239000012895 dilution Substances 0.000 claims abstract description 116
- 230000000694 effects Effects 0.000 claims abstract description 107
- 108091005804 Peptidases Proteins 0.000 claims abstract description 73
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 68
- 239000004365 Protease Substances 0.000 claims abstract description 67
- 239000000411 inducer Substances 0.000 claims abstract description 21
- 241000894006 Bacteria Species 0.000 claims abstract description 17
- 241000605056 Cytophaga Species 0.000 claims abstract description 17
- 239000001963 growth medium Substances 0.000 claims abstract description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 13
- 241000352063 Oerskovia Species 0.000 claims abstract description 7
- 241000186063 Arthrobacter Species 0.000 claims abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 55
- 239000008103 glucose Substances 0.000 claims description 55
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 45
- 229920001503 Glucan Polymers 0.000 claims description 33
- 229940041514 candida albicans extract Drugs 0.000 claims description 12
- 239000012138 yeast extract Substances 0.000 claims description 12
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 230000002101 lytic effect Effects 0.000 abstract description 27
- 235000000346 sugar Nutrition 0.000 abstract description 14
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000010924 continuous production Methods 0.000 abstract description 2
- 238000010564 aerobic fermentation Methods 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 59
- 108090000790 Enzymes Proteins 0.000 description 59
- 229940088598 enzyme Drugs 0.000 description 59
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 48
- 229960001031 glucose Drugs 0.000 description 48
- 235000001727 glucose Nutrition 0.000 description 47
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 43
- 210000000712 G cell Anatomy 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 28
- 239000002609 medium Substances 0.000 description 28
- 238000003786 synthesis reaction Methods 0.000 description 26
- 230000015572 biosynthetic process Effects 0.000 description 25
- 238000000855 fermentation Methods 0.000 description 23
- 230000004151 fermentation Effects 0.000 description 23
- 230000007423 decrease Effects 0.000 description 17
- 230000003287 optical effect Effects 0.000 description 17
- 150000008163 sugars Chemical class 0.000 description 10
- 102100032487 Beta-mannosidase Human genes 0.000 description 9
- 241000950554 Oerskovia sp. Species 0.000 description 9
- 108010055059 beta-Mannosidase Proteins 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 7
- 241001148513 Cytophaga sp. Species 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 102000035195 Peptidases Human genes 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000002028 Biomass Substances 0.000 description 4
- 241000186221 Cellulosimicrobium cellulans Species 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000002797 proteolythic effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000002518 antifoaming agent Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000010923 batch production Methods 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 230000001461 cytolytic effect Effects 0.000 description 3
- 230000002934 lysing effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 241000605108 Flavobacterium johnsoniae Species 0.000 description 2
- 229920001543 Laminarin Polymers 0.000 description 2
- 239000005717 Laminarin Substances 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000186073 Arthrobacter sp. Species 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 101100520151 Mus musculus Pirt gene Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 229910019145 PO4.2H2O Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 108010041102 azocasein Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- CDUFCUKTJFSWPL-UHFFFAOYSA-L manganese(II) sulfate tetrahydrate Chemical compound O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O CDUFCUKTJFSWPL-UHFFFAOYSA-L 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000754 repressing effect Effects 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01039—Glucan endo-1,3-beta-D-glucosidase (3.2.1.39)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/244—Endo-1,3(4)-beta-glucanase (3.2.1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01058—Glucan 1,3-beta-glucosidase (3.2.1.58)
Definitions
- This invention is a method for preparing a yeast cell lytic enzyme system having desired beta (1 ⁇ 3) glucanase and protease activities.
- the method provides an efficient and continuous way to synthesize a lytic enzyme system.
- Yeast cell walls consist of two layers.
- the outer layer is a mannan-protein complex and the inner layer is an alkali-insoluble glucan.
- the inner layer is an alkali-insoluble glucan.
- glucanase displays more profound lytic action than the lytic enzyme (glucanase and protease) alone after a brief treatment of the cells with lytic enzyme.
- the protease appears to be important in the initial attack on the cell surface.
- the opening of polypeptide chains by the protease makes the inner glucan layer of the wall accessible to the glucanase.
- Yeast cell lytic enzyme systems may be produced by either batch or continuous fermentation.
- the continuous process is superior to the batch process with regard to enzyme production.
- the composition (constituent enzymes) of the lytic enzyme systems can be manipulated by the use of different inducers and by altering the dilution rate.
- the existence of lytic enzyme systems with different component activities has a potential for their use in specialized applications. Such applications include production of food grade protein and intracellular enzymes, isolation of intracellular recombinant protein produced in yeast, digestion of cell wall polysaccharides, production of protoplasts, as anticaries agents, in the study of cell wall structure, in the treatment of fungal diseases and as an essential tool for cell fusion, transformation and genetic engineering of yeast.
- GB 1,048,887 discloses a process for producing an enzyme complex having strong proteolytic activity.
- the organism used to produce this enzyme complex is a species of the genus Cytophaga.
- Media compositions and conditions are described for culturing Cytophaga NCIB 9497 in a batch system. Centrifugation of the crude product of the culture and precipitation from aqueous solution with a protein precipitant are described as methods of recovery.
- GB 1,179,935 discloses a process for producing cytolytic enzymes which are capable of lysing the living cells of microorganisms.
- the system is a batch fermentation of Cytophaga johnsonii as well as other species of the genus Cytophaga.
- GB 1,186,998 discloses another process for producing cytolytic enzymes of microorganisms in a batch fermentation.
- the presence of cells of other microorganisms or decomposites thereof in the nutrient medium results in accelerated production of the cytolytic enzymes.
- Cytophaga johnsonii as well as other Cytophagas may be cultured under the disclosed invention.
- US 3,716,452 discloses an enzyme for lysing yeast cell walls.
- the enzyme is produced in a batch fermentation of microorganisms belonging to Arthrobactgr luteus nov.sp.
- the enzyme has activity for lysing cell walls of yeast dead or alive and at any stage of growth.
- Ecky, et al. J. appl. Chem. Biotechnology, vol. 24, pp. 677-686, (1974)
- Levels of beta (1 ⁇ 3) glucanase in the fermentation broth increased sharply as the dilution rate was decreased below 0.20 h -1 .
- Continuous culture has a big advantage over batch culture in relation to enzyme production.
- concentration of the lytic enzymes In continuous culture studies it has been possible to increase the concentration of the lytic enzymes by more than one order of magnitude compared to the batch production. It is also possible to regulate the ratio of glucanase to protease in the lytic enzyme system by using different inducers or altering the dilution rate.
- the present invention is a method for preparing a yeast cell lytic enzyme system having desired beta (1 ⁇ 3) glucanase and protease activities.
- a suitable bacterium which produces the lytic enzyme system is inoculated onto an appropriate growth medium containing predetermined amounts of a sugar as the carbon source (for example, sugar) and an inducer of lytic enzyme activity.
- the bacterium is continuously fermented aerobically at an appropriate dilution rate, the dilution rate being varied to obtain the desired beta (1 ⁇ 3) glucanase and protease activities.
- the resulting lytic enzyme system is recovered.
- the bacterium may be one or more of the group consisting of Cytophaga, Qerskovia or Arthrobacter.
- Fig. 1 Cell and Enzyme Concentrations in Cytophaga NCIB 9497 Continuous Culture as a function of dilution rate (h -1 ).
- Fig. 2 Specific Enzyme Activity in Continuous Culture of Cytophaga sp. (activity/g cells) as a function of dilution rate (h -1 ).
- the medium is comprised of 5 g/L glucose and 10 g/L yeast extract. Values are for yeast lytic activity (YLA, % decrease in OD 6 7 0 after 15 min./g cells, (A)); protease (P, u/g cells, ( ⁇ )); beta (1 ⁇ 3) glucanase (B(1 ⁇ 3), U/L/g cells, ).
- Fig.3. Specific Rate of Enzyme Synthesis in Continuous Culture of Cytophaga sp. (activity/g cells h).
- the medium is comprised of 5 g/L glucose and 10 g/L yeast extract. Values are for beta (1 ⁇ 3) glucanase (B(1 ⁇ 3), U/L/g cells h, ); protease (P, u/g cells h, ( ⁇ )); yeast lytic activity (YLA, % decrease in OD/g cells h, ( ⁇ )).
- Fig. 4 Productivity in Continuous Culture of Cytophaga sp. (activity/L h).
- the medium is comprised of 5 g/L glucose and 10 g/L yeast extract. Values are for yeast lytic activity (YLA, % decrease in OD/L h, ( ⁇ )); protease (P, u/L h, ( ⁇ )); beta (1 ⁇ 3) glucanase (B(1 ⁇ 3), U/L/L h, ); Cells (Cells, OD 670 /L h, (0)).
- Fig. 5 Cell and Enzyme Concentrations in Oerskovia xanthineolytica Continuous Culture as a function of dilution rate (h -1 ).
- Fig. 6 Cell and Enzyme Concetration in Oergkovia xanthineolytica Continuous Culture as a function of dilution rate (h -1 ).
- the medium is comprised of 8 g/L glucose and 0.5 g/L glucan or 2 g/L glucose and 2 g/L glucan. Values are for beta (1 ⁇ 3) glucanase (B(1 ⁇ 3), U/L, protease (P, u, ( ⁇ )).
- Fig. 8 Specific Enzyme Activity in Continuous Culture of Oerskovia sp. (activity/g cells) as a function of dilution rate (h -1 ).
- the medium is comprised of 2 g/L glucose and 2 g/L glucan. Values are for beta (1 ⁇ 3) glucanase (B(1 ⁇ 73), U/L/g cells, protease (P, u/g cells, ( ⁇ )); mannanase (M, U/L/g cells, ; yeast lytic activity (YLA, % decrease in OD/g cells,
- FIG. 9 Specific Enzyme Activity in Continuous Culture of Oerskovia sp. (activity/g cells) as a function of dilution rate (h -1 ).
- the medium is comprised of 8 g/L glucose and 0.5 g/L glucan. Values are for beta (1 ⁇ 3) glucanase (B(1 ⁇ 3), U/L/g cells, ⁇ protease (P, u/g cells, ( ⁇ )); yeast lytic activity (YLA, % decrease in OD/g cells, ( ⁇ )).
- Fig. 10 Specific Rate of Enzyme Synthesis in Continuous Culture of Oerskovia sp. (activity/g cells h) as a function of dilution rate (h -1 ).
- the medium is comprised of 2 g/L glucose and 2 g/L glucan. Values are for protease (P, u/g cells h, ( ⁇ )); mannanase (M, U/L/g cells h, beta (1 ⁇ 3) glucanase (B(1 ⁇ 3), U/L/g cells h, yeast lytic activity (YLA, % decrease in OD/g cells h, ( ⁇ )).
- Fig. 11 Specific Rate of Enzyme Synthesis in Continuous Culture of Oerskovia sp. (activity/g cells h) as a function of dilution rate (h -1 ).
- the medium is comprised of 8 g/L glucose and 0.5 g/L glucan. Values are for protease (P, u/g cells h, ( ⁇ )); beta (1 ⁇ 3) glucanase (B(1 ⁇ 3), U/L/g cells h, yeast lytic activity (YLA, % decrease in OD/g cells h, ( ⁇ )).
- Fig. 12 Productivity in Continuous Culture of Oerskovia sp. as function of dilution rate (h -1 ).
- the medium used was comprised of 2 g/L glucose and 2 g/L glucan. Values are for yeast lytic activity (YLA, % decrease in OD/L h, ( ⁇ )); beta (1 ⁇ 3) glucanase (B(1 ⁇ 3), U/L/L h, protease (P, u/L h, ( ⁇ )); mannanase (M, U/L/L h, (O)); Cells (Cells, (#/mL) x 10 9 , (O).
- Fig. 13 Productivity in Continuous Culture of Oerskovia sp.
- the medium used was comprised of 8 g/L glucose and 0.5 g/L glucan. Values are for yeast lytic activity (YLA, % decrease in OD/L h, ( ⁇ )); beta (1 ⁇ 3) glucanase (B(1 ⁇ 3), U/L/L h, ; protease (P, u/L h, ( ⁇ )); dry weight (D.W., g/L/L h (0)).
- the present invention is a method for preparing a yeast cell lytic enzyme system having desired beta (1 ⁇ 3) glucanase and protease activities.
- a suitable bacteriurn which produces the lytic enzyme system is inoculated onto an appropriate growth medium containing predetermined amounts of carbon source and an inducer of lytic enzyme activity.
- the bacterium is continuously fermented aerobically at an appropriate dilution rate, the dilution rate being varied to obtain the desired protease and beta (1 ⁇ 3) glucanase activities.
- the resulting lytic enzyme system is recovered.
- the bacterium may be one or more of the group consisting of Cytophaga, Oerskovia or Arthrobacter.
- the method may consist of inoculating Oerskovia onto a growth medium containing glucose as the carbon source and yeast wall glucan as the inducer.
- the growth medium may contain up to 20 g/L of glucose and 20 g/L of yeast wall glucan.
- the growth medium may contain 8 g/L glucose and 0.5 g/L yeast wall glucan.
- the dilution rate for the continuous fermentation may be selected so it provides high beta (1 ⁇ 3) glucanase activity.
- the dilution rate may be between about 0.05 and about 0.20 -1 for high beta (1 ⁇ 3) glucanase activity.
- the dilution rate may also be selected so it provides high protease activity.
- the dilution rate may be between about 0.02 and about 0.10h -1 for high protease activity.
- the dilution rate may be selected so it provides high beta (1 ⁇ 3) glucanase activity and low protease activity.
- the dilution rate may be between about 0.15 and about 0.20h -1 for high beta (1 ⁇ 3) glucanase activity and low protease activity.
- Another growth medium for Oerskovia may contain 2 g/L glucose as the carbon source and 2 g/L yeast wall glucan as the inducer.
- the dilution rate for the continuous fermentation may be selected so it provides high beta (1 ⁇ 3) glucanase activity.
- the dilution rate may be between about 0.05 and about 0.14h -1 for high beta (1 ⁇ 3) glucanase activity.
- the dilution rate may also be selected so it provides high protease activity.
- the dilution rate may be between about 0.02 and about 0.14h -1 for high protease activity.
- the dilution rate may also be selected so it provides high beta (1 ⁇ 3) glucanase and low protease activity.
- the dilution rate may be between about 0.15 and about 0.20h -1 for high beta (1 ⁇ 3) glucanase activity and low protease activity.
- the amount of inducer present may be an amount sufficient to produce high levels of beta (1 ⁇ 3) glucanase activity.
- Bacterial strains suitable for the method of this invention include wild type strains of Cytophaga, Oerskovia and Arthrobacter and derivatives thereof.
- the dilution rate which is suitable for the present invention may be between about 0.02 and about 0.40 h -1 .
- the continuous culture may be maintained at a pH and temperature suitable for preparing a yeast cell lytic enzyme system.
- Another aspect of the invention may consist of inoculating Cytophaga onto a growth medium containing glu cose as a carbon source.
- the growth medium may contain 5 g/L glucose.
- the dilution rate for the continuous fermentation may be selected so it provides high beta (1 ⁇ 3) glucanase activity and high protease activity.
- the dilution rate may be between about 0.05 and about 0.10h -1 for high beta (1 ⁇ 3) glucanase and high protease activity.
- the pH for this method may be about 7.0 and the temperature may be about 29°C
- Synthesis of enzymes may be inducible, semi-constitutive or constitutive. Inducible enzymes are synthesized at a low level in the absence of inducers. The uninduced, basal level of enzyme synthesis can vary considerably. When the basal enzyme activity is high, it is classified as semi-constitutive. Constitutive enzymes are synthesized maximally in the presence or absence of an inducer.
- Cytophaga NCIB 9497 has been considered to be constitutive for yeast lytic enzyme synthesis.
- the specific activities of the beta (1 ⁇ 3) glucanase and yeast lytic activity are high at dilution rates between 0.05 and 0.10h -1 . In this range of dilution rates the level of reducing sugars in the fermentation broth is low. Results indicate dual control of beta (1 ⁇ 3) glucanase synthesis by induction and catabolite repression.
- catabolite repression is minimal because the low growth rate of the organism does not lead to an accumulation of repressing catabolites. Synthesis is regulated by the amount of inducer present. Growth rate increases with increasing dilution rate and as a result the rate of enzyme synthesis increases. At a dilution rate between 0.07 and 0.1 h -1 the concentration of the repressor has reached a level high enough to cause significant catabolite repression. As the dilution rate increases the growth rate increases and catabolite repression becomes dominant over induction and the rate of enzyme production drops.
- protease enzyme synthesis does not appear to be under dual control by induction and catabolite repression in the range of dilution rates studied (between 0.03 and 0.30h -1 ). Protease synthesis is subject to catabolite repression but is not induced.
- Reducing sugars in the fermentation broth described above accumulated at dilution rates greater than 0.15 h -1 .
- the reducing sugar content was 6.9 g/L, indicating that most of the measured reducing sugars were glucose.
- washout did not occur.
- the accumulation of reducing sugars at dilution rates above 0.15 h -1 indicates the presence of a second limiting substrate. This substrate is unknown. Dissolved oxygen was never limiting.
- Protease synthesis does not appear, from continuous culture studies, to be inducible. The activity levels therefore are similar in late batch culture and in continuous culture at low dilution rates. Enzyme levels in continuous culture at high dilution rates (when glucose accumulates) are similar to those in batch culture when approximately half the reducing sugars have been metabolized. It appears that the proteolytic activity is made up of activity from more than one protease enzyme and that the syntheses of these enzymes are not regulated together. In carbon limited media, two peaks of specific rate of enzyme synthesis exist; one at dilution rates above 0.15 h -1 and one at dilution rates below 0.15 h -1 .
- the appreciable rate of enzyme synthesis at high dilution rates is evidence that not all the proteolytic enzymes are catabolite repressed. There is also evidence that one of the proteases may be induced by the second, unknown limiting substrate. The peak at low dilution rates indicates that one of the proteases may be weakly induced.
- Oerskovia xanthineolytica Another suitable bacterium of the disclosed method is Oerskovia xanthineolytica. Continuous cultures were carried out using two different media; one with 2 g/L of glucose and 2 g/L of glucan and the other with 8 g/L of glucose and 0.5 g/L of glucan.
- Beta (1 ⁇ 3) glucanase specific activities in the two continuous cultures there is a sharp peak of beta (1 ⁇ 3) glucanase specific activity at low dilution rates.
- the maximum specific activity is more than three times that on the medium of 8 g/L glucose and 0.5 g/L of glucan.
- Beta (1 ⁇ 3) glucanase specific activity in the medium containing 2 g/L glucose and glucan appears to be controlled by both induction and catabolite repression. Protease does not appear to be induced at low dilution rates but is subject to catabolite repression.
- Cytophaga sp. NCIB 9497 was obtained f rom the National Collection of Industrial Bacteria (Aberdeen, Scotland) .
- Oerskovia xanthineolytica LL-G109 was a gift f rom M. Lechavalier, Rutgers University, New Jersey, USA.
- Arthrgbacter sp. GJM-1 was obtained f rom C. Ballou, University of California, Berkeley, USA.
- Saccharomyces cerevisiae NCYC 1006 was f rom the National Collection of Yeast Cultures, Norwich, UK.
- Saccharomyces carlsbergensis was a gift f rom the Stroh Brewing Company, Michigan, USA and the bakers yeast used was Red Star active dried yeast f rom the Universal Food Corporation, Wisconsin, USA.
- Yeast extract - "Ardamine Yep”, (autolysed yeast extract powder), was supplied by Yeast Products Inc., New Jersey, USA.
- Glucose (used in fermentation media) - technical grade, Sigma Chemical Company, Missouri, USA.
- Glucan prepared by alkali extraction from bakers yeast, (Manners et al., 1973a) was a gift from J. Hunter, Department of Chemical Engineering and Applied Chemistry, Columbia University, New York, USA. It was sieved and the fraction smaller than 177 microns (mesh #80) was used.
- Yeast cell walls (used as an inducer) were prepared from Saccharomyces carlsber ⁇ ensis disrupted in a Dyno mill (Willy A. Bachofen AG, Switzerland) for 20 minutes
- OD optical density
- DW dry weight
- viable cell count colony count
- Optical Density was measured in a Spectronic 21 spectrophotometer (Bausch and Lomb, New York, USA). Samples were diluted before reading to fall within the range from 0 to 0.6 on the absorbance scale. When used to estimate growth optical densities were read at 670 nm.
- the colony count method was used to estimate growth in fermentations containing insoluble substances where optical density and dry weight were not useful. Serial dilutions of the culture borth were made in sterile distilled water. 0.1mL of the appropriate dilutions were plated in duplicate. After 72 hours the colonies were counted and the number of cells per unit volume calculated.
- insoluble inducers When insoluble inducers were used they were added directly to the medium resevoir which was stirred throughout the fermentation. The tubing (silicone) was checked daily for buildups of insoluble material.
- Culture purity was checked daily by plating two 0.1 mL sampels of culture borth on nutrient agar plates.
- the sample to be used for enzyme assays was filtered (membrane filter, 0.45 microns) and frozen. When larger volumes of enzyme were needed the supernatent was centrifuged at 2000 rpm for 15 minutes, separated and the enzyme preparation frozen.
- the method used to estimate the overall lytic activity was decrease in optical density in an incubation of whole yeast cells, lytic enzyme and buffer.
- Beta (1 ⁇ 3) Glucanase activity assay equal volumes of enzyme, laminarin (a 3% w/v solution) and buffer (50 mM Tris-HCl, pH 7.3) were incubated at 37 C. The reaction was terminated by boiling in a water bath for 5 minutes. Reducing sugars released were assayed using the Nelson-Somogyi method (Nelson, 1944) or the Micro Nelson method (Spiro, 1966). Standard curves were prepared using glucose.
- Mannanase activity was assayed in the same way Beta (1 ⁇ 3) glucanase except that the substrate used was a 0.5% solution of mannan.
- Glucanase and mannanase activities are expressed in international units, 1 U is that amount of enzyme which releases 1 umole of glucose per minute under specified conditions.
- Protease activity was measured by the method of Rowley and Bull (1977).
- the substrate used was azocasein at a concentration of 2.5 g/L. Equal volumes of substrate and enzyme were incubated at 37 C for 20 minutes. The reaction was terminated by the addition of 2 mL of 3 M TCA (trichloroacetic acid). After centrifugation at 2000 rpm for 30 minutes the absorbance of the supernatant was read at 400 nm. Various blanks and controls were run. The activity is expressed in units (u) where lu equals 1% hydrolysis in 20 min. in the range from 0% to 30%. A unit corresponds to the solubilization of 0.00125 mg. protein per min. per ml. of enzyme solution.
- Glucose concentrations were determined by the PGO (Peroxidase Glucose Oxidase) method, Sigma Technical Bulletin No. 510.
- Cytophaga NCIB 9497 was grown in continuous culture.
- the medium contained 10 g/L of yeast extract and 5 g/L of glucose.
- the pH was controlled at 7 and the temperature at 29°C.
- Steady state conditions at dilution rates from 0.03 h -1 to 0.30 h -1 were analyzed for cell concentration, beta (1 ⁇ 3) glucanase, protease, mannanase and yeast lytic activities as well as reducing sugars present in the fermentation broth.
- the level of glucose (reducing sugars) in the fermentation broth was between 0.5 and 0.8 g/L up to a dilution rate of 0.15 h -1 . At dilution rates above 0.15 h -1 glucose accumulated and another substrate became limiting.
- beta (1 ⁇ 3) glucanase is repressed by glucose.
- Yeast lytic activity is mainly attributable to production of proteolytic enzymes. Activities of beta (1 ⁇ 3) glucanase, protease, mannanase and overall yeast lytic activity are similar to those obtained in batch culture. The beta (1 ⁇ 3) glucanase and protease activities are highest at a dilution rate of about 0.07 h -1 where there is a corresponding peak in yeast lytic activity.
- the enzyme system has a high beta (1 ⁇ 3) glucanase/protease ratio.
- Specific activity (activity/g cells) is calculated using a dry weight per unit optical density correlation of 0.93 g per liter per unit optical density.
- beta (1 ⁇ 3) glucanase activity exhibits a peak of specific activity at dilution rates between about 0.05 and about 0.07 h -1 . At dilution rates above and below this range the specific activities drop significantly. At dilution rates below 0.07 h -1 catabolite repression is minimal and the rate of glucanase synthesis is dependent mainly upon the concentration of inducer present. Catabolite repression increases with increasing dilution rate until it becomes dominant over induction at dilution rates of about 0.07 h -1 and above. Cytophaga NCIB 9497 has in the past been classified as constitutive for enzyme synthesis. It appears from these continuous culture studies that enzyme synthesis in Cytophaga NCIB 9497 is regulated by induction and catabolite repression.
- the specific activity profile for the proteolytic enzyme shows a steady decline with no peak. It does not appear to be inducible but is subject to catabolite repression.
- the specific rate of enzyme synthesis (also called the "specific productivity") is the amount of enzyme activity produced per gram of cells per hour. In the range specific rates of beta (1 ⁇ 3) glucanase and protease synthesis both exhibit peaks. At dilution rates above 0.15 h -1 the rate of glucanase synthesis is low but the rate of protease synthesis shows another peak.
- Productivity is activity per liter per hour for enzyme measurement and optical density per liter per hour for measurement of biomass growth. At dilution rates above 0.25 h -1 a peak of high productivity but low concentration occurs with proteolytic and yeast lytic activities. Productivity of beta (1 ⁇ 3) glucanase activity is low at this range of dilution rates. The productivity of biomass increases slowly with increasing dilution rate. Between rates of about 0.03 and about 0.15 h -1 , all enzyme activities exhibit a sharp peak in productivity. Productivity of beta (1 ⁇ 3) glucanase activity was 20 times greater and yeast lytic activity 4 times greater than such productivity in batch culture.
- Oerskovia xanthinedytica LL-G109 was grown in continuous culture.
- the medium contained 2 g/L glucose as the carbon source and 2 g/L yeast wall glucan as the inducer. Enzyme concentrtion and growth are monitored as well as glucose present in the fermentation broth over a range of dilution rates from 0.03 to 0.38h -1 .
- the level of glucose in the fermentation broth was about 0.02 g/L throughout the range of dilution rates used.
- the level of beta (1 ⁇ 3) glucanase activity is low when dilution rates are below 0.05h -1 .
- the level increases with increasing dilution rate so that activity is high at dilution rates between about 0.05 and about 0.14b -1 . Dilution rates above 0.14h -1 result in low activity.
- Protease activity is low throughout the range of dilution rates studies, and very low at dilution rates above 0.15h -1 .
- Specific activity (activity/g cells) is calculated using a dry weight per unit optical density correlation of 0.61 g per liter per unit optical density.
- the specific activity of beta (1 ⁇ 3) glucanase is high at dilution rates between about 0.03 and about 0.09h -1 , with a peak at a dilution rate of about 0.05h -1 .
- Specific activities at dilution rates below 0.03h -1 and above 0.09h -1 are low.
- Protease specific activity is greatest at dilution rates below 0.05h -1 . Increasing dilution rates result in low protease specific activity.
- the specific rate of enzyme synthesis is the amount of enzyme activity produced per gram of cells per hour. For beta (1 ⁇ 3) glucanase, this value is greatest at dilution rates below 0.15h -1 . At dilution rates above 0.15h -1 the specific rate of enzyme synthesis is low. For protease, this value is highest at low dilution rates but diminishes to a low synthesis rate at dilution rates above 0.10h -1 .
- Productivity is activity per liter per hour for enzyme measurement, and optical density per liter per hour for measurement of biomass growth.
- Beta (1 ⁇ 3) glucanase activity exhibits high productivity at low dilution rates (below 0.2h -1 ) with a maximum at about 0.15h -1 .
- Protease productivity is maximized at a dilution rate of about 0.15 -1 as well.
- Protease productivity above dilution rate of 0.15h -1 is lower but constant, and below a dilution rate of 0.15h -1 steadily declines.
- Oerskovia xanthineolytica LL-G109 was grown in continuous culture.
- the medium contained 8 g/L glucose as the carbon source and 0.5 g/L yeast wall glucan as the inducer. Enzyme concentration and growth are monitored as well as glucose present in the fermentation both over a range of diltuion rates for 0.03 to 0.38h -1 .
- the glucose level was close to 0 g/L up to a dilution rate of 0.28h -1 , above which it accumulates.
- the level of beta (1 ⁇ 3) glucanase activity is high at dilution rates between about 0.03 and about 0.2h -1 .
- Activity is low at dilution rates above 0.2b -1 .
- Protease activity is low throughout the range of dilution rates studies, and very low at dilution rates above 0.15h -1 .
- Specific activity is calculated using a dry weight per unit optical density correlation of 0.61 g per liter per unit optical density.
- the specific activity of beta (1 ⁇ 3) glucanase is greatest at low dilution rates (below 0.15h -1 ).
- For protease this value is highest at dilution rates above 0.25h -1 .
- Productivity is activity per liter per hour for enzyume measurement, and optical density per liter per hour for measurement of biomass growth.
- Beta (1 ⁇ 3) glucanase activity exhibits high productivity at diltuion rates below 0.2h -1 , with a maximum at about 0.15h -1 .
- Protease productivity above a dilution rate of 0.15h -1 is lower but constant, and below a dilution rate of 0.15h -1 steadily declines.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Procédé en continu de préparation d'un système d'enzyme lytique de cellules de levure ayant des activités désirées de bêta (1 - 3) glucanase et protéase. Une bactérie appropriée qui produit le système d'enzyme lytique est inoculée sur un support de croissance approprié contenant des quantités prédéterminées d'une source de carbone (par exemple du sucre) et un inducteur d'activité enzymatique lytique. La bactérie subit une fermentation aérobie en continu, tout en faisant varier la vitesse de dilution pour obtenir les activités désirées de bêta (1 - 3) glucanase et protéase. La bactérie peut être une ou plusieurs des bactéries du groupe constitué de Cytophaga, Oerskovia ou Arthrobacter.A continuous process for the preparation of a lytic enzyme system of yeast cells having desired activities of beta (1 - 3) glucanase and protease. A suitable bacterium which produces the lytic enzyme system is inoculated on an appropriate growth medium containing predetermined amounts of a carbon source (eg sugar) and an inducer of lytic enzymatic activity. The bacteria undergoes continuous aerobic fermentation, while varying the dilution rate to obtain the desired beta (1 - 3) glucanase and protease activities. The bacteria can be one or more of the bacteria from the group consisting of Cytophaga, Oerskovia or Arthrobacter.
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77236385A | 1985-09-04 | 1985-09-04 | |
US772363 | 1985-09-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0236475A1 true EP0236475A1 (en) | 1987-09-16 |
EP0236475A4 EP0236475A4 (en) | 1989-12-19 |
Family
ID=25094823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19860906046 Withdrawn EP0236475A4 (en) | 1985-09-04 | 1986-09-03 | Method of preparing a yeast-cell lytic enzyme system. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0236475A4 (en) |
JP (1) | JPS63500772A (en) |
AU (1) | AU6406086A (en) |
DK (1) | DK227587A (en) |
WO (1) | WO1987001388A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992003557A1 (en) * | 1990-08-17 | 1992-03-05 | Majesty (Her) In Right Of Canada As Represented By The National Research Council Of Canada | RECOMBINANT DNA PRODUCTION OF β-1,3-GLUCANASE |
JPH04158784A (en) * | 1990-10-24 | 1992-06-01 | Tax Adm Agency | Production of yeast cell wall-lysing enzyme and its utilization |
US5919688A (en) * | 1994-10-14 | 1999-07-06 | Novo Nordisk A/S | Enzyme with B-1, 3-glucanase activity |
JPH10507078A (en) * | 1994-10-14 | 1998-07-14 | ノボ ノルディスク アクティーゼルスカブ | Novel enzyme having β-1,3-glucanase activity |
US5637745A (en) * | 1995-01-30 | 1997-06-10 | Elf Atochem North America, Inc. | Organometallic compounds and polymers made therefrom |
EP0904359A1 (en) | 1996-04-12 | 1999-03-31 | Novo Nordisk A/S | AN ENZYME WITH $g(b)-1,3-GLUCANASE ACTIVITY |
PL2655644T3 (en) | 2010-12-22 | 2019-05-31 | Basf Enzymes Llc | Improving fermentation processes and by-products |
HUE042895T2 (en) | 2013-02-21 | 2019-07-29 | Direvo Ind Biotechnology Gmbh | Mycotoxin-binders |
US20150366238A1 (en) | 2013-02-21 | 2015-12-24 | Direvo Industrial Biotechnology Gmbh | Prebiotic animal feed product |
US20160106122A1 (en) | 2013-05-16 | 2016-04-21 | Direvo Industrial Biotechnology Gmbh | Animal feed product for monogastric animals |
EP4054638A1 (en) * | 2019-11-08 | 2022-09-14 | The Trustees Of Columbia University In The City Of New York | Methods for engineering therapeutics and uses thereof |
-
1986
- 1986-09-03 JP JP50507786A patent/JPS63500772A/en active Pending
- 1986-09-03 AU AU64060/86A patent/AU6406086A/en not_active Abandoned
- 1986-09-03 EP EP19860906046 patent/EP0236475A4/en not_active Withdrawn
- 1986-09-03 WO PCT/US1986/001808 patent/WO1987001388A1/en not_active Application Discontinuation
-
1987
- 1987-05-04 DK DK227587A patent/DK227587A/en not_active Application Discontinuation
Non-Patent Citations (3)
Title |
---|
BIOTECHNOLOGY AND BIOENGINEERING * |
CHEMICAL ABSTRACTS * |
See also references of WO8701388A1 * |
Also Published As
Publication number | Publication date |
---|---|
DK227587A (en) | 1987-07-03 |
JPS63500772A (en) | 1988-03-24 |
DK227587D0 (en) | 1987-05-04 |
EP0236475A4 (en) | 1989-12-19 |
WO1987001388A1 (en) | 1987-03-12 |
AU6406086A (en) | 1987-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0236475A1 (en) | Method of preparing a yeast-cell lytic enzyme system | |
Khurshid et al. | Optimization of glucose oxidase production by Aspergillus niger | |
Andrews et al. | Continuous‐culture studies of synthesis and regulation of extracellular β (1‐3) glucanase and protease enzymes from Oerskovia xanthineolytica | |
WO1986001832A1 (en) | THERMOSTABLE beta-AMYLASE | |
US4376167A (en) | Hydrolysis of raffinose by alpha-galactoxidase | |
Paranthaman et al. | Optimization of various culture media for tannase production in submerged fermentation by Aspergillus flavus | |
Andrews et al. | Synthesis and regulation of extracellular β (1–3) glucanase and protease by Cytophaga sp. in batch and continuous culture | |
KR20030096276A (en) | Thermophilic microorganism bacillus coagulans strain sim-7 dsm 14043 for the production of l(+)-lactate from fermentable sugars and their mixtures by means of named microorganisms | |
US4737459A (en) | Regulation and enhancement of enzyme production | |
Rowley et al. | Isolation of a yeast‐lyzing Arthrobacter species and the production of the lytic enzyme complex in batch and continuous‐flow fermentors | |
Murao et al. | Isolation and identification of red yeast cell wall lytic enzyme producing microorganism | |
Sandhu et al. | Production of α-amylase by Saccharomycopsis fibuligera (Syn. Endomycopsis fibuligera) | |
GARG et al. | Continuous production of citric acid by immobilized whole cells of Aspergillus niger | |
LeCorre et al. | Use of a lytic enzyme system from Cytophaga sp. in the lysis of Gram-positive bacteria | |
Wang et al. | Improved extracellular transferase enzyme production by Aspergillus foetidus for synthesis of isooligosaccharides | |
Cheng et al. | Predominant growth of α-amylase regulation mutant in continuous culture of Bacillus caldolyticus | |
CN115786300B (en) | Bacillus amyloliquefaciens with low yield and application thereof | |
CA1222713A (en) | Strains of microorganisms and the use thereof | |
El-Sayed et al. | Semicontinuous penicillin production by two Penicillium chrysogenum strains immobilized in calcium alginate beads | |
Shukla et al. | Study of some parameters for the production of dextranase by Penicillium aculeatum | |
JP3433300B2 (en) | Highly producing yeast cell wall lytic enzyme and method for lysing yeast cell wall using the same | |
JP2707093B2 (en) | New microorganism | |
US3813319A (en) | Process for the manufacture of proteases | |
SU721484A1 (en) | Vnii genetica-42 bacillus subtilis strain as alpha-amylase producent | |
EP0320685B1 (en) | A process for the obtention of thermostable alpha-amylases by culturing superproductive microorganisms at high temperatures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
17P | Request for examination filed |
Effective date: 19870902 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19891219 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19900228 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ANDREWS, BARBARA, A. Inventor name: ASENJO, JUAN, A. |